David L. Dunn

David L. Dunn's AcademicInfluence.com Rankings

David L. Dunn

Philosophy

#9738

World Rank

#13341

Historical Rank

Logic

#6698

World Rank

#8243

Historical Rank

philosophy Degrees

Download Badge

Philosophy

David L. Dunn's Degrees

Doctorate Medicine University of California, San Francisco
Masters Public Health University of California, Berkeley

Why Is David L. Dunn Influential?

(Suggest an Edit or Addition)

(See a Problem?)

David L. Dunn's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Risk factors for chronic rejection in renal allograft recipients. (1993) (692)
A Controlled Clinical Trial of E5 Murine Monoclonal IgM Antibody to Endotoxin in the Treatment of Gram-Negative Sepsis (1991) (656)
Lessons Learned From More Than 1,000 Pancreas Transplants at a Single Institution (2001) (603)
The process of microbial translocation. (1990) (439)
EARLY VERSUS LATE ACUTE RENAL ALLOGRAFT REJECTION: IMPACT ON CHRONIC REJECTION (1993) (373)
Clinical characteristics of post-transplant lymphoproliferative disorders. (1994) (245)
Autologous Islet Transplantation to Prevent Diabetes After Pancreatic Resection (1995) (231)
2,500 Living Donor Kidney Transplants: A Single-Center Experience (2001) (213)
Vascular graft thrombosis after pancreatic transplantation: univariate and multivariate operative and nonoperative risk factor analysis. (1996) (202)
Surgical complications requiring early relaparotomy after pancreas transplantation: a multivariate risk factor and economic impact analysis of the cyclosporine era. (1998) (195)
Differential roles of Mac-1+ cells, and CD4+ and CD8+ T lymphocytes in primary nonfunction and classic rejection of islet allografts (1990) (189)
Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients. (1995) (177)
Causes of Renal Allograft Loss: Progress in the 1980s, Challenges for the 1990s (1991) (167)
Delayed graft function in the absence of rejection has no long-term impact. A study of cadaver kidney recipients with good graft function at 1 year after transplantation. (1996) (166)
Treatment of hospitalized patients with complicated gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin. Synercid Skin and Skin Structure Infection Group. (1999) (162)
Short- and Long‐Term Outcomes of Kidney Transplants with Multiple Renal Arteries (1995) (160)
Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients. (1999) (146)
Human immunodeficiency virus infection in patients with solid-organ transplants: report of five cases and review. (1991) (145)
The surgical risk of pancreas transplantation in the cyclosporine era: an overview. (1997) (145)
Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation (2005) (141)
Intra-abdominal fungal infections after pancreatic transplantation: incidence, treatment, and outcome. (1996) (140)
Selective gut decontamination reduces nosocomial infections and length of stay but not mortality or organ failure in surgical intensive care unit patients. (1992) (133)
Five preventable causes of kidney graft loss in the 1990s: a single-center analysis. (2002) (131)
Role of resident macrophages, peripheral neutrophils, and translymphatic absorption in bacterial clearance from the peritoneal cavity (1985) (131)
Six years of surgical wound infection surveillance at a tertiary care center: review of the microbiologic and epidemiological aspects of 20,007 wounds. (1999) (131)
Immunologic and nonimmunologic factors: different risks for cadaver and living donor transplantation. (2000) (120)
Evolution of kidney, pancreas, and islet transplantation for patients with diabetes at the University of Minnesota. (1993) (117)
A 10‐Year Experience with 290 Pancreas Transplants at a Single Institution (1989) (115)
Rapid Discontinuation of Steroids in Living Donor Kidney Transplantation: A Pilot Study (2001) (111)
Cytomegalovirus (CMV) antigenemia assay is more sensitive than shell vial cultures for rapid detection of CMV in polymorphonuclear blood leukocytes (1992) (104)
Venous thromboembolic complications after kidney and kidney-pancreas transplantation: a multivariate analysis. (1998) (104)
A Prospective Randomized Trial of Steroid‐Free Maintenance Regimens in Kidney Transplant Recipients—An Interim Analysis (2005) (101)
Treatment of invasive cytomegalovirus disease in solid organ transplant patients with ganciclovir. (1991) (100)
Transplant options for patients undergoing total pancreatectomy for chronic pancreatitis. (2004) (100)
Third-generation cephalosporins and vancomycin as risk factors for postoperative vancomycin-resistant enterococcus infection. (1998) (100)
Long-term Immunosuppression, Without Maintenance Prednisone, After Kidney Transplantation (2004) (97)
LONG‐TERM QUALITY OF LIFE AFTER KIDNEY TRANSPLANTATION IN CHILDHOOD (1991) (95)
Outcome at 3 Years with a Prednisone‐Free Maintenance Regimen: A Single‐Center Experience with 349 Kidney Transplant Recipients (2004) (94)
Antibiotic treatment for surgical peritonitis. (1991) (93)
The Adjuvant Effect of Peritoneal Fluid in Experimental Peritonitis: Mechanism and Clinical Implications (1984) (92)
Pancreas transplantation in nonuremic, type I diabetic recipients. (1988) (87)
Analysis of infectious complications occurring after solid-organ transplantation. (1992) (84)
Solitary pancreas transplantation for nonuremic patients with labile insulin-dependent diabetes mellitus. (1997) (82)
RENAL TRANSPLANT FUNCTION AFTER TEN YEARS OF CYCLOSPORINE (1992) (79)
Transplant renal artery stenosis. (1989) (79)
Long-term quality of life after kidney and simultaneous pancreas-kidney transplantation. (1998) (76)
Complications of ureterovesical anastomosis in kidney transplant patients: the Minnesota experience. (1994) (75)
A prospective randomized study of acyclovir versus ganciclovir plus human immune globulin prophylaxis of cytomegalovirus infection after solid organ transplantation. (1994) (74)
Macrophages and translymphatic absorption represent the first line of host defense of the peritoneal cavity. (1987) (74)
Employment patterns after successful kidney transplantation. (1996) (73)
RECIPIENT RISK FACTORS HAVE AN IMPACT ON TECHNICAL FAILURE AND PATIENT AND GRAFT SURVIVAL RATES IN BLADDER‐DRAINED PANCREAS TRANSPLANTS (1994) (73)
Characterization and impact of wound infection after pancreas transplantation. (1994) (71)
Continual intracavitary administration of amphotericin B as an adjunct in the treatment of aspergillus brain abscess: case report and review of the literature. (1992) (70)
Immunotherapy of gram-negative bacterial sepsis: enhanced survival in a guinea pig model by use of rabbit antiserum to Escherichia coli J5. (1982) (69)
Isolation and characterization of murine monoclonal antibodies specific for gram-negative bacterial lipopolysaccharide: association of cross-genus reactivity with lipid A specificity (1987) (69)
Risk factors for prolonged hospitalization after kidney transplants. (1997) (68)
Fungal infections in transplant recipients receiving alemtuzumab. (2005) (67)
Ganciclovir susceptibilities of cytomegalovirus (CMV) isolates from solid organ transplant recipients with CMV viremia after antiviral prophylaxis. (1993) (67)
Cytomegalovirus disease recurrence after ganciclovir treatment in kidney and kidney-pancreas transplant recipients. (1999) (65)
Problems related to immunosuppression. Infection and malignancy occurring after solid organ transplantation. (1990) (64)
De novo cancer in cyclosporine-treated and non-cyclosporine-treated adult primary renal allograft recipients. (1994) (63)
Diagnosis and treatment of cytomegalovirus disease in transplant patients based on gastrointestinal tract manifestations. (1991) (63)
Immunotherapy of gram-negative bacterial sepsis. A single murine monoclonal antibody provides cross-genera protection. (1986) (62)
Single-center 1-15-year results of renal transplantation in patients with systemic lupus erythematosus. (1988) (60)
Decreased acute rejection in kidney transplant recipients is associated with decreased chronic rejection. (1999) (60)
Antibody response of pediatric solid organ transplant recipients to immunization against influenza virus. (1995) (59)
Donor Hyperglycemia as a Minor Risk Factor and Immunologie Variables as Major Risk Factors for Pancreas Allograft Loss in a Multivariate Analysis of a Single Institution's Experience (1992) (59)
Simultaneous pancreas-kidney transplant versus kidney transplant alone in diabetic patients. (1992) (58)
Sequential therapy--a prospective randomized trial of MALG versus OKT3 for prophylactic immunosuppression in cadaver renal allograft recipients. (1992) (56)
Anti‐Endotoxin Monoclonal Antibodies are Protective against Hepatic Ischemia/Reperfusion Injury in Steatotic Mice (2004) (55)
Efficacy of type-specific and cross-reactive murine monoclonal antibodies directed against endotoxin during experimental sepsis. (1985) (55)
Causes of renal allograft loss (1991) (55)
Conversion of Exocrine Secretions From Bladder to Enteric Drainage in Recipients of Whole Pancreaticoduodenal Transplants (1992) (54)
Candida albicans and Escherichia coli are synergistic pathogens during experimental microbial peritonitis. (1997) (53)
Renal transplantation exposes patients with previous Kaposi's sarcoma to a high risk of recurrence. (1996) (52)
Differential sensitivity to Escherichia coli infection in mice lacking tumor necrosis factor p55 or interleukin-1 p80 receptors. (1996) (51)
Gram-negative bacterial sepsis and sepsis syndrome. (1994) (50)
Pancreas after kidney transplants in posturemic patients with type I diabetes mellitus. (2001) (49)
Pregnancy after donor nephrectomy. (1996) (47)
Risk factors for second renal allografts immunosuppressed with cyclosporine. (1991) (45)
Simultaneous pancreas and kidney transplants versus single kidney transplants and previous kidney transplants in uremic patients and single pancreas transplants in nonuremic diabetic patients: comparison of rejection, morbidity, and long-term outcome. (1990) (43)
Peptide derivatives of three distinct lipopolysaccharide binding proteins inhibit lipopolysaccharide-induced tumor necrosis factor-alpha secretion in vitro. (1995) (42)
Incidence, complications, treatment, and outcome of ulcers of the upper gastrointestinal tract after renal transplantation during the cyclosporine era. (1995) (41)
Treatment of recurrent cytomegalovirus disease in patients receiving solid organ transplants. (1993) (41)
B-cell lymphoproliferative disorders in solid-organ transplant patients: detection of Epstein-Barr virus by in situ hybridization. (1992) (40)
A Prospective Study Of Fk506 Versus Csa And Pig Atg In A Porcine Model Of Small Bowel Transplantation (1995) (40)
Pharmacologic basis for high-dose oral acyclovir prophylaxis of cytomegalovirus disease in renal allograft recipients (1991) (39)
Fibrin in peritonitis. IV. Synergistic intraperitoneal infection caused by Escherichia coli and Bacteroides fragilis within fibrin clots. (1984) (39)
The impact of HLA matching on graft survival and on sensitization after a failed transplant--evidence that failure of poorly matched renal transplants does not result in increased sensitization. (1990) (38)
Role of endotoxin and host cytokines in septic shock. (1991) (38)
Mycobacterial infections after kidney transplant. (2005) (38)
Decreased tumor necrosis factor production during the initial stages of infection correlates with survival during murine gram-negative sepsis. (1990) (38)
Duodenal complications in bladder-drained pancreas transplantation. (1997) (36)
An increased incidence of late acute rejection episodes in cadaver renal allograft recipients given azathioprine, cyclosporine, and prednisone. (1990) (36)
Pancreaticoduodenal transplantation with enteric drainage following native total pancreatectomy for chronic pancreatitis: a case report. (1991) (35)
Rapid discontinuation of prednisone in higher-risk kidney transplant recipients. (2004) (35)
Assessment of donor and recipient risk factors on pancreas transplant outcome. (1994) (35)
Pancreas retransplants compared with primary transplants. (1991) (34)
Evidence that combined procurement of pancreas and liver grafts does not affect transplant outcome. (1991) (34)
Rapid Flush Technique for Donor Hepatectomy: Safety and Efficacy of an Improved Method of Liver Recovery for Transplantation. (1988) (34)
Mycoplasma hominis infections occurring in cardiovascular surgical patients. (1996) (33)
Pancreas transplants from living-related donors. (1994) (32)
Fibrin in peritonitis. III. The mechanism of bacterial trapping by polymerizing fibrin. (1982) (31)
Influence of preservation time on outcome and metabolic function of bladder-drained pancreas transplants. (1990) (30)
Protective capacity of polyclonal and monoclonal antibodies directed against endotoxin during experimental sepsis. (1988) (30)
Enhanced survival during murine gram-negative bacterial sepsis by use of a murine monoclonal antibody. (1985) (30)
Mechanisms of the adjuvant effect of hemoglobin in experimental peritonitis. VI. Effects of stroma-free hemoglobin and red blood cell stroma on mortality and neutrophil function. (1983) (30)
Anticore endotoxin F(ab')2 equine immunoglobulin fragments protect against lethal effects of gram-negative bacterial sepsis. (1984) (29)
Intestinal bacterial flora, intestinal pathology, and lipopolysaccharide-induced translocation of intestinal bacteria. (1992) (29)
Should I accept this kidney? (2000) (29)
Pancreas Transplant Pathology: A Morphologic, Immunohistochemical, and Electron Microscopic Comparison of Allogeneic Grafts with Rejection, Syngeneic Grafts, and Chronic Pancreatitis (1991) (29)
Pancreas graft loss caused by intra-abdominal infection. A risk factor for a subsequent pancreas retransplantation. (1996) (29)
ASSESSMENT OF RENAL FUNCTION IN TYPE I DIABETIC PATIENTS AFTER KIDNEY, PANCREAS, OR COMBINED KIDNEY‐PANCREAS TRANSPLANTATION (1991) (28)
Conversion of whole pancreaticoduodenal transplants from bladder to enteric drainage for metabolic acidosis or dysuria. (1990) (28)
Bacterial translocation in a large-animal model of small-bowel transplantation. Portal vs systemic venous drainage and the effect of tacrolimus immunosuppression. (1996) (28)
Acyclovir susceptibilities of herpes simplex virus strains isolated from solid organ transplant recipients after acyclovir or ganciclovir prophylaxis (1993) (27)
Long-term outlook for renal transplant recipients with one-year function. "Doctor, what are my chances"? (1991) (26)
The role of anaerobic bacteria in intraabdominal infections. (1984) (26)
A comparison of single and double pediatric cadaver donor kidneys for transplantation (1989) (26)
Endotoxin promotes synergistic lethality during concurrent Escherichia coli and Candida albicans infection. (1992) (25)
Complications occurring after whole organ duodenopancreatic transplantation: relation to the allograft duodenal segment. (1990) (25)
The role of intestinal flora on the interactions between nonparenchymal cells and hepatocytes in coculture. (1988) (25)
Use of the circular stapler in construction of the duodenoneocystostomy for drainage into the bladder in transplants involving the whole pancreas. (1989) (25)
Treatment of experimental gram-negative bacterial sepsis with murine monoclonal antibodies directed against lipopolysaccharide. (1989) (25)
Bactericidal and endotoxin neutralizing activity of a peptide derived from Limulus antilipopolysaccharide factor. (2000) (25)
Predictors of chronic rejection in renal transplant recipients. (1993) (25)
5,000 kidney transplants--a single-center experience. (2000) (25)
Solid organ transplantation. Where has it been, where is it going? (1990) (25)
Graft Versus Host Response: Clinical and Biological Relevance After Transplantation of Solid Organs (1996) (24)
Posttransplant lymphoproliferative disorders (1991) (23)
Cancer development in renal allograft recipients treated with conventional and cyclosporine immunosuppression. (1991) (23)
The Biological Rationale (2003) (22)
LONG‐TERM METABOLIC FUNCTION OF PANCREAS TRANSPLANTS AND INFLUENCE OF REJECTION EPISODES (1991) (22)
Lessons learned and future hopes: three thousand renal transplants at the University of Minnesota. (1990) (22)
Predicting long-term kidney graft survival: can new trials be performed?1,2 (2003) (21)
Mechanisms of the adjuvant effect of hemoglobin in experimental peritonitis. VII. Hemoglobin does not inhibit clearance of Escherichia coli from the peritoneal cavity. (1983) (21)
Prevention and treatment of multiple organ dysfunction syndrome: lessons learned and future prospects. (2000) (21)
Cystoenteric conversion after whole pancreaticoduodenal transplantation: indications, risk factors, and outcome. (1993) (21)
Retrospective analysis of the role of pancreatic biopsy (open and transcystoscopic technique) in the management of solitary pancreas transplants. (1993) (21)
A deeply invasive Phoma species infection in a renal transplant recipient. (2003) (20)
Successful long-term outcome with 0-haplotype-matched living-related kidney donors (1994) (20)
Pediatric renal transplants--results with sequential immunosuppression. (1992) (20)
Relationship between early vs late acute rejection and onset of chronic rejection in kidney transplantation. (1993) (20)
Effects of Escherichia coli and Bacteroides fragilis on peritoneal host defenses (1985) (19)
Treatment of toxic shock syndrome with endotoxin-neutralizing antibody. (1989) (19)
A single institution's experience with solitary pancreas transplantation: a multivariate analysis of factors leading to improved outcome. (1991) (19)
Immunotherapeutic advances in the treatment of gram-negative bacterial sepsis (1987) (19)
Transplantation of kidneys from zero haplotype-matched living donors and from distantly related and unrelated donors in the cyclosporine era. (1993) (19)
Anti-endotoxin monoclonal antibodies inhibit secretion of tumor necrosis factor-alpha by two distinct mechanisms. (1993) (18)
Diagnosis and treatment of bacteremia and intravascular catheter infections. (1996) (18)
Use of ganciclovir for cytomegalovirus infection. (1992) (18)
Role of nitric oxide during sepsis (1992) (18)
Association of concurrent herpes simplex virus and cytomegalovirus with detrimental effects after renal transplantation. (1984) (17)
New approaches to the diagnosis, prevention, and treatment of cytomegalovirus infection after transplantation. (1991) (17)
Results of pediatric kidney transplantation at the University of Minnesota. (1989) (17)
A third kidney transplant: cost-effective treatment for end-stage renal disease? (1996) (17)
Resistance to graft-versus-host disease following small bowel transplantation. (1991) (16)
Pancreatectomy and auto-islet transplant in patients with chronic pancreatitis (2005) (16)
Pretransplant immunosuppression for pancreas transplants alone in nonuremic diabetic recipients. (2001) (16)
Cross-reactive murine monoclonal antibodies directed against the core/lipid A region of endotoxin inhibit production of tumor necrosis factor. (1990) (16)
Kidney transplant outcome with and without right renal vein extension. (1994) (16)
Solitary pancreas transplantation: alone in nonuremic and after a kidney in uremic diabetic patients. (1991) (16)
Factors influencing pancreas transplant outcome: Cox proportional hazard regression analysis of a single institution's experience with 357 cases. (1991) (16)
Donor impact on outcome of bladder-drained pancreas transplants. (1993) (16)
Clinical islet autotransplantation after pancreatectomy: determinants of success and implications for allotransplantation? (1995) (16)
Donor age and cause of death affect cadaver renal allograft outcome. (1991) (16)
The role of heparin in guinea pig gram negative bacterial sepsis. (1983) (15)
Effects of HLA matching in cadaver renal transplants. (1988) (15)
Inhibition of splenic macrophage tumor necrosis factor alpha secretion in vivo by antilipopolysaccharide monoclonal antibodies. (1994) (15)
Incidence and timing of infections in pediatric renal transplant recipients in the cyclosporine era. (1994) (15)
Recipient risk factors have an impact on technical failure and patient and graft survival rates in bladder-drained pancreas transplants. (1994) (15)
Pathology of transplanted human duodenal tissue : a histologic study, with comparison to pancreatic pathology in resected pancreaticoduodenal transplants (1991) (15)
Antimicrobial therapy of intra-abdominal sepsis. (1992) (14)
Immunosuppression for cadaveric renal allograft recipients: a risk-factor matched comparison of the Minnesota randomized trial with an antilymphoblast globulin, azathioprine, cyclosporine, and prednisone protocol (1989) (14)
A novel endotoxin antagonist attenuates tumor necrosis factor-α secretion (1996) (14)
Molecular Biology of Endotoxin Antagonism (2002) (14)
ANTIBODY IMMUNOTHERAPY OF GRAM‐NEGATIVE BACTERIAL SEPSIS IN AN IMMUNOSUPPRESSED ANIMAL MODEL (1988) (14)
Effect of cyclosporine on renal function in kidney transplant recipients: a 12-year follow-up. (1995) (14)
HLA-identical sibling renal transplants: no rejections with a cyclosporine azathioprine prednisone protocol (1988) (14)
Quality of metabolic control at 2 to 12 years after a pancreas transplant. (1992) (14)
Posttransplant erythrocytosis and the risk of thromboembolic complications: correlation from a prospective randomized study of cyclosporine versus azathioprine-antilymphocyte globulin (1988) (14)
Predicting long-term kidney graft survival: Can new trials be peΡformed? (2003) (13)
Structure/function studies of an endotoxin-neutralizing peptide derived from bactericidal/permeability-increasing protein. (2004) (13)
Hazardous crossing: immunosuppression and nosocomial infections in solid organ transplant recipients. (2001) (13)
The acutely ischemic extremity after kidney transplant: an approach to management. (1998) (13)
Comparison of endotoxin antagonism of linear and cyclized peptides derived from limulus anti-lipopolysaccharide factor. (2006) (13)
MALG vs OKT3 following renal transplantation: a randomized prospective trial. (1991) (13)
Diagnosis and Treatment of Infection (2003) (13)
Binding specificity of polymyxin B, BPI, LALF, and anti-deep core/lipid a monoclonal antibody to lipopolysaccharide partial structures. (2001) (12)
Cancer development in pediatric primary renal allograft recipients. (1994) (12)
Exocrine dysfunction evaluation of bladder-drained pancreaticoduodenal transplants using a transcystoscopic biopsy technique. (1992) (12)
Protective anti-lipopolysaccharide monoclonal antibodies inhibit tumor necrosis factor production. (1992) (12)
Endotoxemia during small bowel transplantation in pigs. (1995) (12)
Design of a potent novel endotoxin antagonist. (1997) (12)
A comparison of pediatric versus adult cadaver donor kidneys for transplantation. (1990) (12)
Maximal use of liver and pancreas from cadaveric organ donors. (1990) (12)
Anti-endotoxin monoclonal antibodies protect by enhancing bacterial and endotoxin clearance. (1993) (12)
2,500 Living donor kidney transplants (2001) (11)
Graft-versus-host disease after multiorgan transplantation. (1991) (11)
Should uremic diabetic patients who want a pancreas transplant receive a simultaneous cadaver kidney-pancreas transplant or a living related donor kidney first followed by cadaver pancreas transplant? (1993) (11)
Sp1 elements regulate transcriptional activity within the murine Toll-like receptor 4 promoter. (2006) (11)
The influence of donor hyperglycemia and other factors on long-term pancreatic allograft survival. (1990) (10)
Pancreas-Transplant Outcome in Relation to Presence or Absence of End-Stage Renal Disease, Timing of Transplant, Surgical Technique, and Donor Source (1989) (10)
Influence of multiple factors (age, transplant number, recipient category, donor source) on outcome of pancreas transplantation at one institution. (1993) (10)
Morbidity following simultaneous pancreas-kidney transplants vs kidney transplants alone in diabetic patients. (1992) (9)
Antibody Immunotherapy of Gram‐negative Bacterial Sepsis (1987) (9)
Detection of pancreatic fluid and urine leakage after pancreas transplantation: value of CT and cystography. (1990) (9)
Effects of three immunosuppressive drug protocols on cadaver renal transplantation costs after 4 years of therapy. (1993) (9)
Bloodstream and intravascular catheter infections (2001) (9)
Is transplant pancreatectomy after graft failure necessary? (1994) (9)
Deep soft-tissue infections (1990) (9)
An immunological comparison of pancreas transplants alone in nonuremic patients versus simultaneous pancreas/kidney transplants in uremic diabetic patients. (1990) (9)
Mortality risk for technically successful vs technically failed bladder drained pancreas transplants and causes of death. (1992) (9)
Kidney transplantation in patients with type I diabetes: 26-year experience at the University of Minnesota. (1992) (9)
Use of novel therapeutic agents for the treatment of serious infection. (1993) (8)
Results with renal transplants performed after previous solitary pancreas transplants. (1994) (8)
Effect of Minnesota antilymphocyte globulin on T-lymphocytes and their subsets during induction therapy in pediatric renal transplantation. (1994) (8)
Effect of simultaneous liver retrieval, retrieval team, and preservation time on cadaver whole-organ, bladder-drained pancreatic allograft survival rates. (1991) (8)
Operative reintervention following early complications after pancreas transplantation. (1994) (8)
Metabolic effects of pretreatment with Escherichia coli J5 antiserum on guinea pig gram-negative bacterial sepsis. (1985) (8)
Erythrocytosis and thromboembolic complications after renal transplantation: results from a randomized trial of cyclosporine versus azathioprine-antilymphocyte globulin. (1988) (8)
Bacterial membrane disrupting dodecapeptide SC4 improves survival of mice challenged with Pseudomonas aeruginosa. (2013) (8)
Does acute tubular necrosis affect renal transplant outcome? The impact of rejection episodes. (1993) (8)
The meaning of research in experimental peritonitis. (1983) (7)
Lymphocyte-derived cytokines augment macrophage tumor necrosis factor-alpha and interleukin-6 secretion during experimental gram-negative bacterial sepsis. (1995) (7)
Long-term follow-up of renal transplantation for Wegener's disease. (1990) (7)
Evaluation of CMV-vue antigenemia assay for rapid detection of cytomegalovirus in mixed-leukocyte blood fractions. (1995) (7)
Kidney retransplantation: patients with a failed second kidney transplant should be considered for a third transplant. (1991) (7)
Appropriate use of antimicrobial agents. Nine principles. (1991) (7)
Development and potential use of antibody directed against lipopolysaccharide for the treatment of gram-negative bacterial sepsis. (1990) (7)
Pancreatic allograft loss secondary to periallograft gastrointestinal cytomegalovirus ulceration. (1990) (7)
Renal transplantation in patients with paraproteinemias (1990) (7)
Salvage therapy of open, infected surgical wounds: a retrospective review using Techni-Care. (2000) (7)
Neutropenia in an HIV-1-infected renal transplant recipient treated with zidovudine. (1988) (7)
Ileal and colon conduits in renal transplantation (1990) (7)
Antiendotoxin agents share molecular homology within their lipopolysaccharide binding domains. (1999) (7)
Effect of host immunomodulation on the prevention of islet allograft primary nonfunction in a murine model. (1990) (7)
Problems Related to Immunosuppressions (1990) (6)
Renal transplantation at the University of Minnesota during the 1980s. (1987) (6)
Accelerated internalization and detoxification of endotoxin by anti-lipopolysaccharide antibody is an Fc receptor--mediated process. (2001) (6)
Influence of preservation time on the early function of pancreas transplants. (1990) (6)
Immunization with antibodies that mimic LPS protects against gram negative bacterial sepsis. (1997) (6)
Adjunctive azathioprine and antilymphocyte serum immunosuppression with cyclosporine. (1988) (6)
Relevance of tumor necrosis factor to graft-versus-host disease after small bowel transplantation (1993) (6)
Prevention of cytomegalovirus disease with oral acyclovir (1991) (6)
Effect of donor pre‐treatment with anti‐lymphocyte globulin on small bowel transplantation in rats (1991) (6)
Transplantation of single and double kidneys from pediatric donors (1991) (5)
Pancreatic retransplants: an analysis of the outcome. (1990) (5)
Simultaneous treatment of concurrent rejection and tissue invasive cytomegalovirus disease without detrimental effects upon patient or allograft survival (1992) (5)
Converting exocrine drainage from bladder to bowel in recipients of whole pancreaticoduodenal transplants. (1992) (5)
SHOULD I ACCEPT THIS KIDNEY (1999) (5)
Pancreas transplants in nonuremic and posturemic diabetic patients. (1992) (5)
Long-term outcome of renal transplantation in patients with systemic lupus erythematosus. (1989) (5)
Vaccines and antibody immunotherapy in surgical patients. (1987) (5)
Long-term outcome in 1-year graft survivors: comparison of diabetic and nondiabetic populations. (1991) (5)
Corrigendum: Treatment of hospitalized patients with complicated Gram-positive skin and skin structure infections: Two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin (Journal of Antimicrobial Chemotherapy (1999) 44 (263-273)) (1999) (5)
Macrophages expressing a fusion protein derived from bactericidal/permeability-increasing protein and IgG are resistant to endotoxin. (1996) (5)
Renal transplantation in patients with polycystic kidney disease: A single-center experience (1989) (5)
Serious bacterial infections of the skin and soft tissues (1995) (4)
Kidney transplant or retransplant can effectively treat congenital nephrotic syndrome: a single-center experience. (1994) (4)
Human herpes virus 6 infections in hospitalized renal transplant recipients (1991) (4)
INVASIVE FUNGAL INFECTIONS IN PANCREAS TRANSPLANT RECIPIENTS RECEIVING ALEMTUZUMAB (2004) (4)
A novel endotoxin antagonist attenuates tumor necrosis factor-alpha secretion. (1996) (4)
Diagnosis and Treatment of Opportunistic Infections in Immunocompromised Surgical Patients (2000) (4)
Optimizing the immediate posttransplant prednisone dose : a prospective randomized trial (1992) (4)
Diagnosis and treatment of cytomegalovirus disease in pediatric renal transplant recipients. (1994) (4)
Multiorgan transplantation in the rat: Development of a new microsurgical model (1991) (4)
History repeats itself. Connections and causality in the study of surgical infections. (1994) (3)
Complications of chronic pelvic radiation injury. (2004) (3)
Pediatric donors - A risk factor in renal retransplantation (1989) (3)
Combined procurement of pancreas and liver grafts does not affect transplant outcome. (1990) (3)
Enterococcal sepsis and lung microvascular injury in sheep. (1990) (3)
Risk factors for kidney transplant acute rejection: a multivariate analysis. (2001) (3)
Contribution of local cytokine production to the systemic host septic response. (1994) (3)
Fulminant post-transplant lymphoproliferative disorder presenting as multisystem organ failure (1992) (3)
A comparison of two cyclosporine protocols at the University of Minnesota. (1988) (3)
Pancreas transplant pathology: an immunohistochemical comparison of allografts with rejection, syngeneic grafts, and chronic pancreatitis. (1991) (3)
EMERGING RESISTANCE IN STAPHYLOCOCCI AND ENTEROCOCCI (1996) (3)
HANDBOOK MEDIATORS * , SEPTIC SHOCK (2012) (3)
Does endotoxin accelerate rejection in a cardiac allograft model? (1996) (2)
NF-κB elements regulate transcriptional activity within the murine MyD88 promoter (2006) (2)
Cytomegalovirus infection and disease after solid-organ transplantation: Epidemiology, prevention, and therapy (2000) (2)
Pancreas induces graft-vs-host disease when transplanted en bloc with liver and small bowel. (1992) (2)
Mechanisms of clearance from the peritoneal cavity. (1986) (2)
Graft versus host disease after small bowel transplantation or lymphocyte transfer is associated with the appearance of Tumor Necrosis Factor in the serum (1990) (2)
Monoclonal antibodies for diagnosis and treatment. (1993) (2)
RECOMMENDED LITERATURE 1. Schwartz's Principles of Surgery, 2009 (2010) (2)
Predicting mortality in septic patients. (1995) (2)
Lithium for Zidovudine-Induced Neutropenia in AIDS-Reply (1988) (2)
Phagocyte--monokine interactions during intra-abdominal sepsis: potential for immunointervention. (1992) (2)
Impact of HLA-ABDR match on chronic rejection in kidney transplants. (2001) (2)
The association of Escherichia coli virulence and pulmonary microvascular damage. (1989) (2)
Impact of baseline HIV-1 integrase polymorphisms on virological outcome in a large European cohort of patients starting a raltegravir-containing regimen (2011) (2)
Murine monoclonal antibody directed against lipopolysaccharide (LPS) inhibits Kupffer cell activation by endotoxin in vitro. (1988) (2)
Pediatric kidney retransplantation: 30 years of experience at a single institution. (1994) (2)
Comparative pulmonary effects of intraperitoneal inoculation of live v dead Escherichia coli. (1984) (2)
Bacterial Translocation Across a Histologically Intact Intestinal Mucosa (1991) (2)
Multiorgan procurement does not affect the immediate outcome of kidney transplants (1991) (2)
Anti-lipopolysaccharide monoclonal antibodies inhibit macrophage TNF messenger RNA synthesis in vitro. (1993) (2)
Cytomegalovirus infections in the immunocompromised transplant patient. Prevention of cytomegalovirus disease with oral acyclovir. (1991) (2)
Fate of native polycystic kidneys left in situ after renal transplantation (1990) (2)
A multivariate analysis of HLA mismatching in solitary pancreas transplantation (1991) (1)
CONTROVERSIES REGARDING THE USE OF ANTI-ENDOTOXIN MONOCLONAL ANTIBODIES (1993) (1)
Influence of pretransplant cytomegalovirus serology and treatment of rejection upon disease after kidney and kidney plus pancreas transplantation. (1992) (1)
Department of Surgery, University of Minnesota, Minneapolis. (2005) (1)
A rapid procedure for purifying IgM monoclonal antibodies from murine ascites using a DEAE-disk. (1993) (1)
Pancreas transplantation in non-uremic diabetic recipients (1991) (1)
Effects ofEscherichia coli andBacteroides fragilis on Peritoneal HostDefenses (1985) (1)
PANCREAS(PX) TRANSPLANTATION (TX) ALONE (PTA) FOR NON‐UREMIC DIABETIC PATIENTS: A 20 YEAR EXPERIENCE.: Abstract# 607 (2000) (1)
Pancreas Transplantation at the University of Minnesota: 1966–2005 (2006) (1)
Nosocomial infections and sepsis syndrome in critically ill surgical patients (1996) (1)
Presidential address: Discovery (1997) (1)
An analysis of pancreatic retransplants with bladder drainage. (1990) (1)
[Infections in kidney and pancreas transplantation]. (1997) (1)
Relevance of tumor necrosis factor to graft‐versus‐host disease after small bowel transplantation (1993) (1)
Importance of lymphoid tissue for survival of small bowel allografts. (1995) (1)
THE ASSOCIATION BETWEEN CMV INFECTION AND CHRONIC REJECTION IN KIDNEY TRANSPLANT RECIPIENTS (1999) (0)
New approaches to living donor renal transplantation [corrected]. (1989) (0)
Mechanisms of GVHD produced by small bowel transplantation (1991) (0)
Use of bacterial mutant to study the adjuvant effect of hemoglobin in experimental Escherichia coli peritonitis (1984) (0)
LOCALIZATION OF BACTERICIDAL AND ENDOTOXIN NEUTRALIZING ACTIVITY TO A COMMON DETERMINANT OF BACTERICIDAL/PERMEABILITY-INCREASING PROTEIN (BPI) (1999) (0)
A complicated case of skin cancer in a renal allograft recipient. (1994) (0)
DECREASED ACUTE KIDNEY TRANSPLANT REJECTION IS ASSOCIATED WITH DECREASED CHRONIC REJECTION (1999) (0)
Cyclosporine and immunosuppressive regimens in renal transplantation. (1988) (0)
Addition of positive charge augments the anti-endotoxin properties of LALF-based peptides (2003) (0)
Mechanisms of graft versus host disease produced by small bowel transplantation (2007) (0)
Molecular anatomy of the pro-inflammatory catalytic activity of lipopolysaccharide-binding protein (LPB) (2003) (0)
Successful canine small intestinal allotransplantation: ex vivo irradiation and cyclosporine pretreatment. (1991) (0)
disease in renal allograft recipients. acyclovir prophylaxis of cytomegalovirus Pharmacologic basis for high-dose oral (2013) (0)
Pharmacologic Basis forHigh-Dose OralAcyclovir Prophylaxis of Cytomegalovirus Disease inRenalAllograft Recipients (1991) (0)
[Simultaneous removal of liver and pancreas does not have an effect on results of transplantation of these organs]. (1991) (0)
67: Identification of an Sp1 element within the murine toll-like receptor-4 promoter that regulates transcriptional activity (2007) (0)
PEDIATRIC RENAL TRANSPLANTS—RESULTS WITH SEQUENTIAL IMMUNOSUPPRESSION1,2 (1992) (0)
Augmented enhancement of in vitro production of inflammatory cytokines... (1999) (0)
THE IMPACT (?) OF HLA‐ABDR MATCH ON CHRONIC REJECTION (CR).: Abstract# 670 (2000) (0)
The carboxyl terminus of TIRAP is critical to MyD88-dependent TLR-4 signaling (2004) (0)
A PROSPECTIVE RANDOMIZED STUDY OF ACYCLOVIR VERSUS GANCICLOVIR PLUS HUMAN IMMUNE GLOBULIN PROPHYLAXIS OF CYTOMEGALOVIRUS INFECTION AFTER SOLID ORGAN TRANSPLANTATION1,2 (1994) (0)
Increased E. coli virulence results in increased lung microvascular injury following E. coli peritonitis (1984) (0)
Endotoxins in Septic Shock (2019) (0)
NO barrier too tight. (1999) (0)
TIR domain important for mal-mediated host-endotoxin intracellular signaling (2005) (0)
INCIDENCE OF MYCOBACTERIAL INFECTIONS AFTER KIDNEY TRANSPLANT (2004) (0)
Society of University Surgeons. Presidential address: discovery. (1997) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With David L. Dunn?

David L. Dunn is affiliated with the following schools:

University of Minnesota